Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis

Area of Science:

• Infectious Diseases
• Dermatology
• Rheumatology

Background:

• Erythema migrans is the hallmark rash of Lyme disease, yet patient recall of tick bites is infrequent.
• Lyme disease diagnosis and treatment require understanding the spectrum of clinical presentations and appropriate testing.

Observation:

• The classic erythema migrans rash presents in various forms, including annular homogenous erythema, central erythema, central clearing, or central purpura.
• Serologic testing is often negative early in erythema migrans, making clinical diagnosis paramount.
• Lyme arthritis typically manifests as a swollen, painful knee with positive serology.

Findings:

• Successful treatment of erythema migrans is achieved with 20-day oral antibiotic courses (doxycycline, amoxicillin, or cefuroxime axetil).
• Lyme arthritis generally responds to 28-day oral antibiotic regimens, though persistent effusions may necessitate synovectomy.
• Prolonged antibiotic therapy beyond 8 weeks for Lyme disease is not indicated, and antibiotic-resistant chronic Lyme disease has not been proven.

Implications:

• Clinical recognition of erythema migrans is crucial for timely Lyme disease diagnosis, even without a reported tick bite.
• Standard antibiotic durations are effective for early Lyme disease and Lyme arthritis, preventing unnecessary prolonged treatment.
• Understanding the etiology of persistent joint effusions in Lyme arthritis is important for appropriate patient management.